Fecundis — Seed · €2.4M

Fecundis, a Barcelona Science Park-based medtech spin-off led by CEO Rita Vassena, closed a €2.4M seed round to fund clinical testing and market launch of HyperSperm, its assisted-reproduction sperm technology. The round was led by Chicago-based DuneGlass Capital with LatAm funds Zentynel Frontier Investments and GRIDX joining; the company also keeps an operations base in Rosario/Buenos Aires, Argentina.